Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about renal cell carcinoma
Recent news which mentions renal cell carcinoma
Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer
February 17, 2022
Tickers
ALKS
Tags
Phase 1 Trial
Kidney Cancer
General
From
Benzinga
Bristol Myers, Exelixis Tout Additional Opdivo/Cabometyx Combo Data From Kidney Cancer Trial
February 15, 2022
Tickers
BMY
EXEL
Tags
Biotech
Briefs
renal cell carcinoma
From
Benzinga
Aveo Says Tivozanib Patients Up To 5X More Likely To Experience Long-Term PFS Vs. Nexavar In Kidney Cancer
February 15, 2022
Tickers
AVEO
BAYRY
Tags
Penny Stocks
Briefs
Biotech
From
Benzinga
Merck's Keytruda Wins European Approval For Post-Surgery Kidney Cancer
January 27, 2022
Tickers
MRK
Tags
Health Care
Market News
News
From
Benzinga
EMA's CHMP Backs Approval For Merck's Keytruda In Adjuvant Setting For Kidney Cancer
December 17, 2021
Tickers
MRK
Tags
General
Benzinga
European Medicines Agency
From
Benzinga
Bristol Myers Touts 5-Year Kidney Cancer Data For Opdivo-Yervoy Combo Therapy
September 16, 2021
Tickers
BMY
PFE
Tags
Benzinga
Briefs
Biotech
From
Benzinga
Exelixis' Cabometyx Combo Trial Shows Benefit In Kidney Cancer Regardless Of Prior Surgery
September 16, 2021
Tickers
BMY
EXEL
PFE
Tags
Market News
EXEL
PFE
From
Benzinga
Exelixis - Takeda's Cabometyx Scores Approval In Japan For Kidney Cancer
August 26, 2021
Tickers
BMY
EXEL
TAK
TKPHF
Tags
TAK
Health Care
Biotech
From
Benzinga
Merck's Belzutifan Wins FDA Approval As First Drug For Rare VHL Tumors
August 16, 2021
Tickers
MRK
Tags
Benzinga
oncology
Biotech
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.